External Evaluation of a Bayesian Warfarin Dose Optimization Based on a Kinetic-Pharmacodynamic Model-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

External Evaluation of a Bayesian Warfarin Dose Optimization Based on a Kinetic-Pharmacodynamic Model

Published:2022-01-01 Issue:1 Volume:45 Page:136-142
ISSN:0918-6158
Container-title:Biological and Pharmaceutical Bulletin
language:en
Short-container-title:Biol. Pharm. Bull.

Author:

Aoyama Takahiko¹,Hirai Toshinori²,Tsuji Yasuhiro³,Miyamoto Aoi¹,Itoh Toshimasa⁴,Iwamoto Takuya²,Matsumoto Yoshiaki¹

Affiliation:

1. Laboratory of Clinical Pharmacokinetics, School of Pharmacy, Nihon University

2. Department of Pharmacy, Mie University Hospital, Faculty of Medicine, Mie University

3. Center for Pharmacist Education, School of Pharmacy, Nihon University

4. Department of Pharmacy, Tokyo Women’s Medical University, Medical Center East

Publisher

Pharmaceutical Society of Japan

Subject

Pharmaceutical Science,Pharmacology,General Medicine

Link

https://www.jstage.jst.go.jp/article/bpb/45/1/45_b21-00778/_pdf

Reference31 articles.

1. 1) Hirsh J, Dalen J, Anderson DR, Poller L, Bussey H, Ansell J, Deykin D. Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range. Chest, 119 (Suppl.), 8S–21S (2001).

2. 2) Verhoef TI, Redekop WK, Daly AK, van Schie RM, de Boer A, Maitland-van der Zee AH. Pharmacogenetic-guided dosing of coumarin anticoagulants: algorithms for warfarin, acenocoumarol and phenprocoumon. Br. J. Clin. Pharmacol., 77, 626–641 (2014).

3. 3) Reynolds MW, Fahrbach K, Hauch O, Wygant G, Estok R, Cella C, Nalysnyk L. Warfarin anticoagulation and outcomes in patients with atrial fibrillation: a systematic review and metaanalysis. Chest, 126, 1938–1945 (2004).

4. 4) Wattanachai N, Kaewmoongkun S, Pussadhamma B, Makarawate P, Wongvipaporn C, Kiatchoosakun S, Vannaprasaht S, Tassaneeyakul W. The impact of non-genetic and genetic factors on a stable warfarin dose in Thai patients. Eur. J. Clin. Pharmacol., 73, 973–980 (2017).

5. 5) Sconce EA, Khan TI, Wynne HA, Avery P, Monkhouse L, King BP, Wood P, Kesteven P, Daly AK, Kamali F. The impact of CYP2C9 and VKORC1 genetic polymorphism and patient characteristics upon warfarin dose requirements: proposal for a new dosing regimen. Blood, 106, 2329–2333 (2005).

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Kinetic–pharmacodynamic model of warfarin for prothrombin time–international normalized ratio in Japanese patients;British Journal of Clinical Pharmacology;2023-12-10

2. Variations in prothrombin time-international normalized ratio caused by drug-drug interaction in patients receiving warfarin: A retrospective observational study;Int. Journal of Clinical Pharmacology and Therapeutics;2023-04-01

3. Pharmacokinetic/Pharmacodynamic Modeling and Simulation of the Analgesic Effects of Pentazocine Using Perioperative Real-World Data;Biological and Pharmaceutical Bulletin;2022-12-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3